Medical Device and Diagnostic Industry (MDDI)

MD&DI is a specialized magazine focused on the medical device and diagnostic sector, published by UBM Canon based in Los Angeles. The magazine features peer-reviewed articles that tackle various technological challenges, as well as summaries of important business, industry, and regulatory matters. Since its founding in 1979, MD&DI has evolved from a print publication, which had a monthly circulation of 48,040 in 2009, to a fully online platform boasting a claimed readership of 89,000.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#504730

United States

#237861

Health/Health

#4388

Traffic sources

Monthly visitors

Articles

Edwards Unveils Favorable 8-Year Resilia Data

6 days ago | mddionline.com | Omar Ford

Edwards Lifesciences reported new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary Resilia tissue technology have significantly improved long-term outcomes compared to those receiving non-Resilia tissue bioprosthetic valves.
3D Printing Is Still Revolutionizing Medical Technology

1 week ago | mddionline.com | Norbert Sparrow

The use of 3D printing to fabricate patient-specific implants has made great strides over the years, but surgical guides and pre-operative models continue to be the most widespread application of 3D printing in the medical space. The reason is simple: “The barrier to entry is relatively low,” explains Sona Dadhania, principal technology analyst at IDTechEx and a contributor to the "3D Printing and Additive Manufacturing 2024-2034: Technology and Market Outlook” report.
Old-School Surface Treatment Materials Make a Comeback for 3D Printed Devices

1 week ago | mddionline.com | Susan Shepard

Everything old is new again, as the saying goes. In this case, it’s hydroxyapatite, a material that is at least as old as humankind, since it naturally occurs in our bodies. Because it is biocompatible, it makes a perfect surface treatment for medical implants. Although Craig Rosenblum’s company, Himed, developed a formulation of the material for surface treatments some 30 years ago, it has recently found new purpose in coatings for 3D printed dental and medical implants.
RadNet to Acquire iCad to Boost Cancer Screening Leadership

1 week ago | mddionline.com | Amanda Pedersen

After the market closed Tuesday, Los Angeles, CA-based RadNet announced its plans to acquire Nashua, NH-based iCad in an all-stock transaction. iCad stockholders will receive 0.0677 shares of RadNet common stock for each share of iCad common stock they hold at the closing of the merger.
How J&J Is Navigating Tariffs and Investing in US Manufacturing

1 week ago | mddionline.com | Amanda Pedersen

As expected, tariffs were top of mind for medtech analysts covering Johnson & Johnson's first-quarter earnings call Tuesday morning. CEO Joaquin Duato reminded call participants that in March, J&J announced its commitment to invest more than $55 billion in the US over the next four years in manufacturing, R&D, and technology. "This represents a 25% increase in investment compared to the previous four years," Duato said.
Wearable Neuro Device Approved to Assist Rehab of Stroke & SCI

1 week ago | mddionline.com | Joe Darrah

Regardless of severity, recovery from stroke or spinal cord injury (SCI) is always a challenging process. This is especially true when the patient’s hands are affected.
A New Era in Cardiac Education and Patient Care

1 week ago | mddionline.com | Susan Shepard

“By 2030, almost half of the U.S. population will suffer from cardiovascular disease,” said Bertrand Moal, PhD, MD, and CEO of DESKi, in an interview with MD+DI. Worse, he explained, there will not be enough cardiologists to keep up with the demand for these patients who need the specialized care. “And so, we need to bring expertise from the specialists to the hands of the novice healthcare professional to be able to change the way we are treating patients,” Moal said.
FDA Green-Lights Next Phase of Carmat's Artificial Heart Study

1 week ago | mddionline.com | Amanda Pedersen

Paris, France-based Carmat is now a beat closer to bringing its total artificial heart to the U.S. market. FDA gave Carmat conditional approval to initiate the second cohort of its early feasibility study with the Aeson artificial heart in the United States. The company has been developing the device for years, aiming to provide a therapeutic alternative for people suffering from advanced biventricular heart failure.
Winners, Losers, and Those Caught in Between

1 week ago | mddionline.com | Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006. Amanda's weekly op-ed, Pedersen's POV, was a 2023 Neal Award Winner for "Best Commentary." Pedersen's POV was also a 2024 Neal Awards finalist for "Best Commentary."Amanda Pedersen poses with her Jesse H.
Laser Duo Speeds UDI Marking for Medtech

1 week ago | mddionline.com | David Hutton

Laser Photonics Corp. (LPC) and subsidiary Control Micro Systems Inc. have ramped up their joint research and development efforts to fast-track development of advanced laser cold marking technology aimed at meeting the stringent unique device identification (UDI) requirements in plastic medical device manufacturing. While industrial laser marking is widely used, the companies noted that medical devices are subject to far more stringent FDA requirements for UDI and traceability.